Immunic, Inc.
IMUX
$15.37
-$0.04-0.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.59M | -19.30M | -25.58M | -26.82M | -25.47M |
| Total Depreciation and Amortization | 33.00K | 42.00K | 40.00K | 43.00K | 43.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.62M | 1.65M | 3.66M | 1.95M | 2.10M |
| Change in Net Operating Assets | 10.64M | -1.67M | 1.74M | 214.00K | 1.56M |
| Cash from Operations | -17.30M | -19.28M | -20.14M | -24.61M | -21.78M |
| Capital Expenditure | -2.00K | -11.00K | -67.00K | -36.00K | -47.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -11.00K | -67.00K | -36.00K | -47.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 201.39M | 59.00K | 0.00 | 65.52M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.75M | -- | -- | -- | -- |
| Cash from Financing | 188.64M | 59.00K | 0.00 | 65.52M | -- |
| Foreign Exchange rate Adjustments | -193.00K | -416.00K | 29.00K | 133.00K | 459.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.15M | -19.65M | -20.18M | 41.01M | -21.36M |